Titan Pharmaceuticals, Inc. (TTNP)
Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform. The company offers Probuphine implant for the maintenance treatment of opioid use disorder in clinically stable patients in Canada and the European Union. It is also developing kappa opioid agonist peptide program (TP-2021) for use in combination with ProNeura technology for the treatment of chronic pruritus; nalmefene implant program for the prevention of opioid relapse following detoxification of patients suffering opioid use disorder; and other programs, including HIV preventative therapeutic and a contraceptive from a single ProNeura implant for women and adolescent girls. The company was incorporated in 1992 and is based in South San Francisco, California.
$5.24M
Mr. David Elliot Lazar
11.00
South San Francisco, CA
Jan 18, 1996
-0.86
$-6.64
0.06
0.27
-5,479.21%
-0.64
-0.02
-5.24
35.15
0.06
-1,039.16%
-946.23%
Similar stocks (17)
Third Harmonic Bio, Inc.
THRD
Foghorn Therapeutics Inc.
FHTX
ZIVO Bioscience, Inc.
ZIVO
NeuroBo Pharmaceuticals, Inc.
NRBO
GeoVax Labs, Inc.
GOVX
SAB Biotherapeutics, Inc.
SABS
Indaptus Therapeutics, Inc.
INDP
Senti Biosciences, Inc.
SNTI
Vaccinex, Inc.
VCNX
Cadrenal Therapeutics, Inc.
CVKD
Fresh Tracks Therapeutics, Inc.
FRTX
Lixte Biotechnology Holdings, Inc.
LIXT
Pasithea Therapeutics Corp.
KTTA
Processa Pharmaceuticals, Inc.
PCSA
Quoin Pharmaceuticals, Ltd.
QNRX
Salarius Pharmaceuticals, Inc.
SLRX
Comera Life Sciences Holdings, Inc.
CMRA
ETF Exposure (2)
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (17)
Third Harmonic Bio, Inc.
THRD
Foghorn Therapeutics Inc.
FHTX
ZIVO Bioscience, Inc.
ZIVO
NeuroBo Pharmaceuticals, Inc.
NRBO
GeoVax Labs, Inc.
GOVX
SAB Biotherapeutics, Inc.
SABS
Indaptus Therapeutics, Inc.
INDP
Senti Biosciences, Inc.
SNTI
Vaccinex, Inc.
VCNX
Cadrenal Therapeutics, Inc.
CVKD
Fresh Tracks Therapeutics, Inc.
FRTX
Lixte Biotechnology Holdings, Inc.
LIXT
Pasithea Therapeutics Corp.
KTTA
Processa Pharmaceuticals, Inc.
PCSA
Quoin Pharmaceuticals, Ltd.
QNRX
Salarius Pharmaceuticals, Inc.
SLRX
Comera Life Sciences Holdings, Inc.
CMRA
ETF Exposure (2)
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Extended Market Index Fund
VXF
0%